News

Enbridge Achieves Record Financial Performance for 2024

Enbridge Achieves Record Financial Performance for 2024

Enbridge Delivers Strong Financial Results for 2024

Enbridge Inc. (TSX: ENB) has announced impressive fourth quarter financial results for 2024. The company reaffirmed its strong financial guidance for 2025, positioning itself strongly within the energy sector. Enbridge's commitment to operational excellence and innovation continues to drive its market position and financial successes.

Financial Highlights

For the full year of 2024, Enbridge reported GAAP earnings of $5.1 billion or $2.34 per common share, a decrease from 2023's $5.8 billion or $2.84 per share. Adjusted earnings reached $6.0 billion or $2.80 per share, an increase from $5.7 billion or $2.79 per share in the prior year. Financial stability is emphasized by Enbridge achieving its financial guidance for the 19th consecutive year, showcasing the predictability of its business model.

Key Results

  • Full-year cash provided by operating activities totaled $12.6 billion, compared to $14.2 billion in 2023.
  • Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) was $18.6 billion, representing a 13% increase over last year’s $16.5 billion.
  • Distributable cash flow (DCF) was $12.0 billion, up 6% from $11.3 billion in 2023.
  • A quarterly dividend increase of 3.0% to $0.9425 per share reflects a continued commitment to returning value to shareholders.

Business Strategy and Operational Updates

Enbridge's strategic focus on energy infrastructure has enabled significant project execution across its business units. Notably, the company has recently placed $5 billion in organic projects into service and sanctioned an additional $8 billion across various new initiatives. These projects align with Enbridge's vision of sustainable energy delivery and operational efficiency.

CEO Insights

Greg Ebel, President and CEO of Enbridge, highlighted the company’s historic success in 2024, particularly the completion of a significant $19 billion acquisition of three leading U.S. gas utilities. This acquisition positions Enbridge as the largest natural gas utility franchise in North America, enhancing its capacity to meet a growing natural gas demand.

Industry Impact and Growth Potential

The upcoming year is set to continue this momentum. Enbridge expects the majority of growth in 2025 to stem from contributions from these recent acquisitions along with the benefits from various energy projects anticipated to become operational. The company is also evaluating further opportunities for capacity expansion in their Liquids Pipelines network to better serve customer needs.

Commitment to Renewable Energy

In parallel with its conventional energy projects, Enbridge is also heavily investing in renewable energy. The company has sanctioned approximately 1,200 net MW of projects aimed to be operational by 2026. This initiative demonstrates Enbridge's commitment to the energy transition and sustainable practices.

Financial Outlook for 2025

Looking ahead, Enbridge reaffirms its financial guidance for 2025 with expectations for adjusted EBITDA between $19.4 billion and $20.0 billion. DCF per share is projected between $5.50 and $5.90. This outlook emphasizes the company's confidence in its growth strategy and operational effectiveness moving forward.

Frequently Asked Questions

What were Enbridge's earnings in 2024?

Enbridge reported GAAP earnings of $5.1 billion or $2.34 per common share for the full year 2024.

How much did Enbridge increase its dividend?

Enbridge increased its quarterly dividend by 3.0% to $0.9425 per share.

What is the projected EBITDA for Enbridge in 2025?

Enbridge projects adjusted EBITDA for 2025 to be between $19.4 billion and $20.0 billion.

How much cash was provided by operations in 2024?

Cash provided by operating activities was $12.6 billion for 2024.

What are Enbridge's key growth initiatives for 2025?

Key growth initiatives include contributions from recent acquisitions and the achievement of operational efficiencies across their energy projects.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 6

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 4

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 6

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 9

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Crunch Fitness Expands with New State-of-the-Art Facility

Updated Category News Views 448

Exciting Launch of Crunch Fitness in New Location Crunch Fitness is set to enhance the fitness experience for all in its newest location, a state-of-the-art facility designed to invigorate the community. Positioned at 4701 Colleyville Blvd, this modern gym promises to redefine conventional workout spaces. With elegant lighting and a sleek design,Crunch Colleyville aims to...

Continue Reading
Meketa Capital Unveils New Infrastructure Fund for Advisors

Updated Category News Views 57

Exciting Launch of the Meketa Infrastructure Fund Meketa Capital has made an impactful move by launching the Meketa Infrastructure Fund, which is aimed at registered investment advisors (RIAs). This fund is now accessible through Fidelity’s Institutional Wealth Services and National Financial marketplaces, expanding options for advisors and their clients. Access to a...

Continue Reading
BrightPath Child Care Expands with New School Opening

Updated Category News Views 521

BrightPath Early Learning Opens New Facility in Sugar Grove BrightPath Early Learning and Child Care, a leading provider of early childhood education, proudly announces the opening of its new location in Sugar Grove. This marks a significant milestone as it expands its reach in the Chicago area, adding another option for families seeking high-quality child care services....

Continue Reading
Baltic Horizon Fund Announces SDR Program Termination Plans

Updated Category News Views 133

Baltic Horizon Fund's Termination of SDR Program On February 13, 2025, Baltic Horizon Fund (the Fund) announced the decision to terminate its Swedish Depositary Receipts (SDR) program and subsequently delist from Nasdaq Stockholm. This significant change comes as the Fund aims to streamline its operations and enhance efficiency in the market. Notice of Termination for SDR...

Continue Reading
Cereno Scientific Advances Clinical Trials for PAH Treatment

Updated Category News Views 184

Cereno Scientific Submits Protocol for Phase IIb Trial of CS1 Cereno Scientific, a pioneering biotech, has taken a significant step forward by submitting its Phase IIb trial protocol for CS1 to the U.S. Food and Drug Administration (FDA). This submission marks an important milestone in the company's efforts to enhance healthcare for patients living with pulmonary arterial...

Continue Reading